A new series of highly potent non-peptide bradykinin B2 receptor antagonists incorporating the 4-heteroarylquinoline framework. Improvement of aqueous solubility and new insights into species difference.

Source:http://linkedlifedata.com/resource/pubmed/id/15027853

J. Med. Chem. 2004 Mar 25 47 7 1617-30

Download in:

View as

General Info

PMID
15027853